NP-1250, an ABCG2 inhibitor, induces apoptotic cell death in mitoxantrone-resistant breast carcinoma MCF7 cells via a caspase-independent pathway

Scheffer GL, Maliepaard M, Pijnenborg AC, et al: Breast cancer resistance protein is localized at the plasma membrane in mitoxantrone- and topotecan-resistant cell lines. Cancer Res. 60:2589–2593. 2000.PubMed/NCBI

Kuo MT: Roles of multidrug resistance genes in breast cancer chemoresistance. Adv Exp Med Biol. 608:23–30. 2007. View Article : Google Scholar : PubMed/NCBI

Guo X, Ma N, Wang J, Song J, Bu X, Cheng Y, et al: Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells. BMC Cancer. 8:3752008. View Article : Google Scholar : PubMed/NCBI

Honma K, Iwao-Koizumi K, Takeshita F, Yamamoto Y, Yoshida T, Nishio K, et al: RPN2 gene confers docetaxel resistance in breast cancer. Nat Med. 14:939–948. 2008. View Article : Google Scholar : PubMed/NCBI

Katoh SY, Ueno M and Takakura N: Involvement of MDR1 function in proliferation of tumour cells. J Biochem. 143:517–524. 2008. View Article : Google Scholar : PubMed/NCBI

Chen Z, Liu F, Ren Q, Zhao Q, Ren H, Lu S, et al: Suppression of ABCG2 inhibits cancer cell proliferation. Int J Cancer. 126:841–851. 2010.PubMed/NCBI

Nakagawa M, Schneider E, Dixon KH, Horton J, Kelley K, Morrow C and Cowan KH: Reduced intracellular drug accumulation in the absence of P-Glycoprotein (mdr1) overexpression in mitoxantrone-resistant human MCF-7 breast cancer cells. Cancer Res. 52:6175–6181. 1992.PubMed/NCBI

Wakabayashi K, Nakagawa H, Adachi T, Kii I, Kobatake E, Kudo A and Ishikawa T: Identification of cysteine residues critically involved in homodimer formation and protein expression of human ATP-binding cassette transporter ABCG2: a new approach using the flp recombinase system. J Exp Ther Oncol. 5:205–222. 2006.

Saito H, Hirano H, Nakagawa H, Fukami T, Oosumi K, Murakami K, et al: A new strategy of high-speed screening and quantitative structure-activity relationship analysis to evaluate human ATP-binding cassette transporter ABCG2-drug interactions. J Pharmacol Exp Ther. 317:1114–1124. 2006. View Article : Google Scholar

Wang T, Kajino K, Abe M, Tan K, Maruo M, Sun G, et al: Suppression of cell death by the secretory form of N-terminal ERC/mesothelin. Int J Mol Med. 26:185–191. 2010.PubMed/NCBI

Fujimura T, Shinohara Y, Tissot B, Pang PC, Kurogochi M, Saito S, et al: Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease of normal subjects. Int J Cancer. 122:39–49. 2008. View Article : Google Scholar : PubMed/NCBI

Janicke RU, Sprengart ML, Wati MR and Porter AG: Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J Biol Chem. 273:9357–9360. 1998. View Article : Google Scholar : PubMed/NCBI

Wilkinson B and Gilbert HF: Protein disulfide isomerase. Biochim Biophys Acta. 1699:35–44. 2004. View Article : Google Scholar : PubMed/NCBI

Keenan J, Murphy L, Henry M, Meleady P and Clynes M: Proteomic analysis of multidrug-resistance mechanisms in adriamycin-resistant variants of DLKP, a squamous lung cancer cell line. Proteomics. 9:1556–1566. 2009. View Article : Google Scholar : PubMed/NCBI

Liu Y, Liu H, Han B and Zhang JT: Identification of 14-3-3sigma as a contributor to drug resistance in human breast cancer cells using functional proteomic analysis. Cancer Res. 66:3248–3255. 2006. View Article : Google Scholar : PubMed/NCBI

Montano MM, Ekena K, Delage-Mourroux R, Chang W, Martini P and Katzenellenbogen BS: An estrogen receptor-selective coregulator that potentiates the effectiveness of antiestrogens and represses the activity of estrogens. Proc Natl Acad Sci USA. 96:6947–6952. 1999. View Article : Google Scholar : PubMed/NCBI

Zubovych I, Doundoulakis T, Harran PG and Roth MG: A missense mutation in Caenorhabditis elegans prohibitin 2 confers an atypical multidrug resistance. Proc Natl Acad Sci USA. 103:15523–15528. 2006.PubMed/NCBI

Shau H and Kim A: Identification of natural killer enhancing factor as a major antioxidant in human red blood cells. Biochem Biophys Res Commun. 199:83–88. 1994. View Article : Google Scholar : PubMed/NCBI

Kowaltowski AJ, Netto LE and Vercesi AE: The thiol-specific antioxidant enzyme prevents mitochondrial permeability transition evidence for the participation of reactive oxygen species in this mechanism. J Biol Chem. 273:12766–12769. 1998. View Article : Google Scholar

Chung YM, Yoo YD, Park JK, Kim YT and Kim HJ: Increased expression of peroxiredoxin II confers resistance to cisplatin. Anticancer Res. 21:1129–1133. 2001.PubMed/NCBI